Inactive Instrument

Highlights Medipharm Labs Corp Toronto S.E.

Equities

CA58504D1006

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

MediPharm Labs Narrows Q4 Loss, Revenue Grows; Up 10.5%	Mar. 27	MT
MediPharm Labs Narrows Q4 Loss, Revenue Grows	Mar. 27	MT
MediPharm Labs Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
MediPharm Labs Corp. Brief: Q4 Revenue $9.131 Million; Says Annual Revenue and Adjusted EBITDA Improve by 50%	Mar. 27	MT
MediPharm Labs Offers Update on German Cannabis Legalization; Up Nearly 6%	Mar. 25	MT
IM Cannabis Corp. Brief: Notes This Provides IMC Germany with a "Unique Opportunity" to further accelerate growth in 2024 after delivering 180% growth in 2023	Mar. 25	MT
IM Cannabis Corp. Brief: Adds By rescheduling medical cannabis, from a narcotic to a regular prescription, the German medical cannabis market is Expected to deliver "Strong" growth	Mar. 25	MT
IM Cannabis Corp. Brief: Says Expects "Accelerated Growth" in Germany from that Country's "Groundbreaking" Cannabis Legalization	Mar. 25	MT
MediPharm Labs Offers Update on German Cannabis Legalization	Mar. 25	MT
MediPharm Labs Corp. Brief: Says "Historic change is a significant positive step in removing the stigma related to medical cannabis"	Mar. 25	MT
MediPharm Labs Corp. Brief: Providing Update on German Cannabis Legalization	Mar. 25	MT
MediPharm Labs Provides Update on German Cannabis Legalization	Mar. 25	CI
MediPharm Labs Corp. Says Achieved Pharmaceutical GMP Certification with Brazilian Health Authority	Feb. 07	MT
MediPharm Labs Corp. Brief: Says Achieved Pharmaceutical GMP Certification with Brazilian Health Authority	Feb. 07	MT
MediPharm Labs Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
MediPharm Labs Corp. Updated On $9 Million Settlement Agreement; All Tilray Shares Sold and Converted to Cash	23-10-25	MT
MediPharm Labs Corp. Brief: Updating on $9 Million Settlement Agreement; All Tilray Shares Sold and Converted to Cash	23-10-25	MT
Tilray Brands, Inc. acquired 1000652011 Ontario Inc. from MediPharm Labs Corp. for CAD 8.5 million.	23-10-03	CI
MediPharm Labs Corp. Says Settled an Outstanding Claim for $9 Million	23-10-02	MT
MediPharm Labs Corp. Brief: Says Settled an Outstanding Claim for $9 Million	23-10-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Medipharm Labs Corp Toronto S.E.

Equities

CA58504D1006

Highlights

Filters